Sign in
4

Changes in Ownership

INOVIO PHARMACEUTICALS, INC. Filed Acc 0001055726-18-000009

Chief Operating Officer gave up 12,549 shares (to pay taxes)

  • Chief Operating Officer acquired 45,434 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Sardesai Niranjan · Chief Operating Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2018-03-09 Exercise or conversion : show line 1 in the form +25,000 115,601 D
2018-03-09 Shares withheld for taxes : show line 2 in the form −6,896 $4.51 $31,101 108,705 D
2018-03-10 Exercise or conversion : show line 3 in the form +20,434 129,139 D
2018-03-10 Shares withheld for taxes : show line 4 in the form −5,653 $4.51 $25,495 123,486 D

Table II: Derivative

2 lines
Date Transaction Shares Underlying Owned after D/I
2018-03-09 Exercise or conversion : show line 5 in the form Restricted Stock Unit −25,000 25,000 25,000 D
2018-03-10 Exercise or conversion : show line 6 in the form Restricted Stock Unit −20,434 20,434 40,866 D
Loading xslF345X03/wf-form4_152098057831916.xml…